Growth Differentiation Factor 15
-
Subject Areas on Research
-
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
-
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
-
Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
-
Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
-
Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.
-
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
-
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.
-
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
-
Growth Differentiation Factor-15-Induced Contractile Activity and Extracellular Matrix Production in Human Trabecular Meshwork Cells.
-
Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
-
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
-
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
-
Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failure.
-
Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.
-
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
-
Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
-
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
-
Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.
-
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
-
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
-
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.